BCL2 and glioblastoma: In conclusion, we report here the newly identified anticancer effect of 5-AcTMF on GBM cells, which is mainly attributed to 5-AcTMF-mediated suppression of the JAK2-STAT3-BCL-2/BCL-xL antiapoptotic signaling axis (Figure 7).